MedTrace Logo

Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device

NCT01338467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2015-06-16

No results posted yet for this study

Summary

The aim of the study is to evaluate the effectiveness and the safety of the EYEOP treatment using High Intensity Focused Ultrasound in refractory glaucoma patients.

Conditions

Interventions

DEVICE

EYEOP device

Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP device

Sponsors & Collaborators

  • EyeTechCare

    lead INDUSTRY

Principal Investigators

  • Philippe DENIS, MD · Croix Rousse Hospital - Lyon - France

  • Laurent FARCY · EyeTechCare

  • Florent APTEL, MD · University Hospital - Grenoble - France

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-06-30
Completion
2013-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01338467 on ClinicalTrials.gov